| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 09/01/2005 | CA2828128A1 Contrast agents for myocardial perfusion imaging |
| 09/01/2005 | CA2567042A1 Enrichment methods for the detection of pathogens and other microbes |
| 09/01/2005 | CA2558064A1 Contrast medium for thrombus formation |
| 09/01/2005 | CA2556426A1 Wound dressings comprising a protein polymer and a polyfunctional spacer |
| 09/01/2005 | CA2556213A1 Contrast agents for myocardial perfusion imaging |
| 09/01/2005 | CA2554965A1 Antibodies specific for activated confirmation of lfa-1 |
| 08/31/2005 | EP1567858A2 Fish disease models and uses thereof |
| 08/31/2005 | EP1567550A2 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 08/31/2005 | EP1567199A2 Neuroprotective activity of activated protein c is independent of its anticoagulant activity |
| 08/31/2005 | EP1567144A2 Method of making, and the use of cytotoxic agents containing elemental selenium |
| 08/31/2005 | EP1420688A4 Macromolecular imaging agents for liver imaging |
| 08/31/2005 | EP0939653B1 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 08/31/2005 | CN1662247A Medical composition for prevention and/or treatment of constipation and symptom caused by constipation |
| 08/31/2005 | CN1662238A Peptide deformylase activated prodrugs |
| 08/31/2005 | CN1661373A New target drone of medication for anti hepatitis b virus and application |
| 08/31/2005 | CN1660446A Method and application of producing disease model of local cerebral ischemia by using macaque |
| 08/31/2005 | CN1660445A Model of endometriosis and modeling method |
| 08/30/2005 | US6936701 Glycoconjugates and methods |
| 08/30/2005 | US6936589 Concurrent administering of druh and hypotonic sugar solution |
| 08/30/2005 | US6936475 Hybrid green fluorescent protein (GFP) which binds, measures and detects calcium using fluorescent/chemiluminescence resonance energy transfer (F/CRET) |
| 08/25/2005 | WO2005077407A1 Targeted atherosclerosis treatment |
| 08/25/2005 | WO2005077343A2 Novel drugs and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases |
| 08/25/2005 | WO2004078027A3 Materials and methods for near-infrared and infrared intravascular imaging |
| 08/25/2005 | WO2004064611A3 Resorbable radiopaque markers and related medical implants |
| 08/25/2005 | US20050188426 Transgenic zebrafish for use as animal model in identifying modulators of heart function |
| 08/25/2005 | US20050187161 peptide sequences that selectively bind to fungal surface molecules; Biopanning and Rapid Analysis of Selective Interactive Ligands (BRASIL) provides for rapid and efficient separation of phage that bind to fungal surface molecules |
| 08/25/2005 | US20050187147 Compositions and methods for increasing drug efficiency |
| 08/25/2005 | US20050186637 Hybridoma cell for use in propagation of immunoglobulins for treatment and prevention of autoimmune, pancreatic, blood and cell proliferative disorders |
| 08/25/2005 | US20050186575 Corona-virus-like particles comprising functionally deleted genomes |
| 08/25/2005 | US20050186568 Enzymatic polypeptides for use as drug screening tools; pharmacological toxicity |
| 08/25/2005 | US20050186247 Such as silk, which induce a fibrotic response in the surrounding tissue such that the device is anchored in situ and its performance is enhanced; prosthetic joint for example |
| 08/25/2005 | US20050186138 Methods and compositions for modulating circadian rhythm |
| 08/25/2005 | US20050186137 Determining the subject's rate of engagement in a pleasurable activity in a novel environment with and without an active agent then comparing the rates |
| 08/25/2005 | CA2819492A1 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 08/25/2005 | CA2559889A1 Targeted atherosclerosis treatment |
| 08/24/2005 | CN1658902A Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis and therapy |
| 08/23/2005 | US6932960 Complexes with radionuclides; for use as contrast agent in magnetic resonance imaging (MRI); as parasiticide, viricide, or as chelation therapy of iron overload such as thalassemia; optimal combination of lipophilicity and hydrophilicity |
| 08/18/2005 | WO2005075531A1 Amphiphilic block and graft copolymers containing heavy elements, method for the production thereof, and use of the same as x-ray contrast agents |
| 08/18/2005 | WO2005074996A2 Lat1 transporter expressed in blood brain barrier cells |
| 08/18/2005 | WO2005074992A1 Pharmaceutical form of reduced toxicity for oral administration of indomethacin |
| 08/18/2005 | WO2005074941A1 Inhibition of protein kinase c-related kinase (prk) as a treatment for cardiac hypertrophy and heart failure |
| 08/18/2005 | WO2005045041A3 Rna interference mediated inhibition of cholesteryl ester transfer protein (cetp) gene expression using short interfering nucleic acid (sina) |
| 08/18/2005 | WO2005044310A3 Embolic compositions comprising polymer particle and radiopaque material |
| 08/18/2005 | WO2005035003A3 Compositions and methods for increasing drug efficiency |
| 08/18/2005 | WO2005007868A3 Controlled platelet activation to monitor therapy of adp antagonists |
| 08/18/2005 | US20050182027 radiolabeled phosphonium or ammonium salts that accumulate in mitochondria of cancer cells; cancer diagnosis; tomography; distinguishes between tissue inflammation and tumors; e.g. F18-3-fluoropropyltriphenyl phosphonium bromide |
| 08/18/2005 | US20050182023 Process to prepare semicarbazones' and/or tiosemicarbazones' formulations using cyclodextrins and their derivatives and products obtained by this process |
| 08/18/2005 | US20050181989 Selective substrates for matrix metalloproteinases |
| 08/18/2005 | US20050181976 coupled to therapeutic proteins or peptides; biochemical conjugation |
| 08/18/2005 | US20050181038 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 08/18/2005 | US20050180922 able to incorporate a range of hydrophobic drugs into the cores; preferred copolymers comprise a hydrophilic PEO (polyethylene oxide) block and one of several hydrophobic blocks that drive self-assembly |
| 08/18/2005 | US20050180921 Contrast agents to improve gastrointestinal tract opacification during abdominal and pelvic CT scans |
| 08/18/2005 | US20050180920 Oral contrast media composition for computerized axial tomographic examinations and method |
| 08/18/2005 | US20050180919 Stent with radiopaque and encapsulant coatings |
| 08/18/2005 | DE102004006048A1 Magnetic resonance contrast agent composition with retarded extravasation, e.g. for imaging cerebro-spinal lesions, comprising molecular dispersed gadolinium complex and colloidal biopolymer in carrier |
| 08/18/2005 | DE102004005304A1 Schwerelementhaltige amphiphile Block- und Pfropf-Copolymere, Verfahren zu ihrer Herstellung und ihre Verwendung als Röntgenkontrastmittel Heavy element-containing amphiphilic block and graft copolymers, processes for their preparation and their use as X-ray contrast agent |
| 08/18/2005 | CA2555632A1 Inhibition of protein kinase c-related kinase (prk) as a treatment for cardiac hypertrophy and heart failure |
| 08/18/2005 | CA2555306A1 Humanized antibody |
| 08/17/2005 | EP1564293A1 Neural thread protein gene expression and detection of Alzheimer's disease |
| 08/17/2005 | EP1563281A1 Method and apparatus for time resolved optical imaging of biological tissues as part of animals |
| 08/17/2005 | EP1563067A2 Methods for the identification of agents that modulate the structure and processing of a membrane bound precursor protein |
| 08/17/2005 | EP1563066A2 Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein |
| 08/17/2005 | EP1562641A2 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 08/17/2005 | EP1562639A1 Method and arrangement for producing contrast agent for magnetic resonance imaging |
| 08/17/2005 | EP1562638A1 Lymph node contrast agent |
| 08/17/2005 | EP1562637A1 Contrast medium for representing lymph nodes |
| 08/17/2005 | EP1224215B1 NON-ANAPHYLACTIC FORMS OF GRASS POLLEN Ph1 p 6 ALLERGEN AND THEIR USE |
| 08/17/2005 | EP1049767B1 A transgenic rabbit that expresses a functional human lipoprotein (a) |
| 08/17/2005 | CN1655671A Animal model for toxicology and dose prediction |
| 08/17/2005 | CN1654075A Gel form medical ultrasonic transmission medium |
| 08/16/2005 | US6930088 Conformationally constrained backbone cyclized somatostatin analogs |
| 08/11/2005 | WO2005072780A2 Cellular labeling for nuclear magnetic resonance techniques |
| 08/11/2005 | WO2005072744A1 Vitreous-visualizing agents |
| 08/11/2005 | WO2005072097A2 Toll-like receptor 9 modulators |
| 08/11/2005 | WO2003075846A3 Uses of monoclonal antibody 8h9 |
| 08/11/2005 | US20050177881 Using presence of allelic mutations in lysosomal acid lipase (LIPA) and cholesterol 25-hydroxylase (CH25H) as diagnostic indicator of nervous system disorders |
| 08/11/2005 | US20050176944 Intracellular signaling polypeptide for identifying modulator for prevention and treatment cell proliferative, endocrine, autoimmune/inflammatory, neurological, gastrointestinal, reproductive, developmental, and vesicle trafficking disorders |
| 08/11/2005 | US20050176691 Combination therapy for the treatment of estrogen-sensitive disease |
| 08/11/2005 | US20050176664 RNA interference mediated inhibition of cholinergic muscarinic receptor (CHRM3) gene expression using short interfering nucleic acid (siNA) |
| 08/11/2005 | US20050176053 Using toluidine blue O and methylene blue stains as diagnostic tool in detection of cell proliferative disorders |
| 08/11/2005 | US20050175980 Quantitative assay of the angiogenic and antiangiogenic activity of a test molecule |
| 08/11/2005 | US20050175702 Contains magnetic and/or metallic colloids; produced by suspension polymerization |
| 08/11/2005 | US20050175657 An injectable mixture of a bulking agent and a fibrosing agent chosen from silkworm silk, spider silk, talc, chitosan, polylysine, fibronectin, bleomycin or connective tissue growth factors; increased fibrosis between implant and host tissue |
| 08/11/2005 | US20050175543 Agents for magnetic imaging method |
| 08/11/2005 | US20050175542 System, formulation, kit and method for tagging colonic residue in an individual |
| 08/11/2005 | US20050175541 Enhanced drug delivery |
| 08/11/2005 | US20050175540 High contrast optoacoustical imaging using nonoparticles |
| 08/11/2005 | US20050175539 Compositions inhibiting rejection in organ transplantation and method of using the same |
| 08/11/2005 | US20050175538 Small animal light intensity monitor |
| 08/11/2005 | CA2560544A1 Cellular labeling for nuclear magnetic resonance techniques |
| 08/11/2005 | CA2554410A1 Biotherapeutics, diagnostics and research reagents |
| 08/10/2005 | EP1561425A1 Indocyanine dyes |
| 08/10/2005 | EP1560924A2 Molecular lymphatic mapping of sentinel lymph nodes |
| 08/10/2005 | EP1560603A1 Method for measuring pancreatic metabolism |
| 08/10/2005 | EP1096941B1 Bone marrow cells as a source of neurons for brain and spinal cord repair |
| 08/10/2005 | EP1084145B1 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use thereof for diagnosis and therapy of tumors and diseases associated with angiogenesis |
| 08/10/2005 | EP0977049B1 PROCESS FOR OBTAINING IMAGES AND SPECTRA OF THE EXTRACELLULAR pH BY MAGNETIC RESONANCE WITH EXTRINSINC INDICATORS CONTAINING 1H OR 19F |
| 08/10/2005 | CN1651094A CT blood bath contrast medium and its preparation method |
| 08/10/2005 | CN1651093A Liver specificity CT contrast medium and its preparation method |
| 08/10/2005 | CN1213715C Antimicrobial caries-detecting composition |